This study is looking at care and outcomes for people with Schizophrenia or Bipolarity I. Taking part may give some people access to Iloperidone, but direct benefit is not guaranteed.

In United States

Schizophrenia, BipolarityDrugFrom 12 Years to 17 Years

Countries: United States
Sponsor: Vanda Pharmaceuticals
Condition: Schizophrenia, Bipolarity

View study

RecruitingNCT06229210

Safety and Tolerability study of Lumateperone in Pediatric people with Schizophrenia, Bipolarity or Autism Spectrum Disorder

This observational study is following people with Schizophrenia, bipolarity, or Autism Spectrum Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United States

Bipolarity, SchizophreniaDrugFrom 5 Years to 17 Years

Countries: United States, Colombia, Serbia
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Bipolarity, Schizophrenia

View study

RecruitingNCT07589621

Safety Behavior Fading Versus Progressive Muscle Relaxation for Appearance Concerns

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disorders, AnxietyBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Florida State University
Condition: Eating disorders, Anxiety

View study

RecruitingNCT07210255

SAINT in Postpartum Depression (PPD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionBehavioralFrom 18 Years to 45 Years

Countries: United States
Sponsor: Magnus Medical
Condition: Depression

View study

RecruitingNCT05541926

Scaling up e-Connect in Juvenile Probation Settings

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SuicidalityBehavioralOver 10 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Suicidality

View study

RecruitingNCT05885542

SCORE Emerging Adult Cannabis Use & Stress

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 25 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: Addiction

View study

RecruitingNCT06552741

Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionObservationalFrom 18 Years to 99 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Addiction

View study

RecruitingNCT06376734

Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, Anxiety, ...DeviceFrom 18 Years to 65 Years

Countries: United States
Sponsor: Brigham and Women's Hospital
Condition: Depression, Anxiety, ...

View study

RecruitingNCT05623306

SEEG-Guided DBS for OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDeviceFrom 22 Years to 75 Years

Countries: United States
Sponsor: Casey H. Halpern, M.D.
Condition: OCD

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.